Collegium Pharmaceutical competitors

Collegium Pharmaceutical Competitors include Depomed, Aimmune Therapeutics, Flex Pharma and Genprex.
Add company...
Collegium Pharmaceutical
Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of products for the treatment of chronic pain.
Depomed
Depomed is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other.
Aimmune Therapeutics
Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies.
Flex Pharma
Flex Pharma, Inc. develops clinically proven products and treatments for muscle cramps and spasms.
Genprex
Genprex is a biopharmaceutical company developing molecular therapies for the treatment of cancer.
Founding Date
Founding Date
2002
Founding Date
1995
Founding Date
2011
Founding Date
2014
Founding Date
2009
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Canton, US HQ
Locations
Newark, US HQ
Locations
Brisbane, US HQ
Greater London, GB
Locations
Boston, US HQ
Locations
Austin, US HQ
Employees
Employees
234
Employees
490
Employees
12220% increase
Employees
30
Employees
8
Valuation ($)
Valuation ($)
561.4 m
Valuation ($)
466.6 m
Valuation ($)
1.6 b
Valuation ($)
11.4 m
Valuation ($)
26.8 m
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
577
Twitter followers
479
Twitter followers
10.2 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$380.7m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$1.3m (FY, 2017)
Revenue (est.)
N/A
Net income
Net income
($74.9m) (FY, 2017)
Net income
($102.5m) (FY, 2017)
Net income
($80.8m) (FY, 2016)
Net income
($34.4m) (FY, 2017)
Net income
($3.3m) (FY, 2017)

Operating

Patents Issued
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
2 (FY, 2016)
Patents Issued
N/A
Patents Issued
30 (Q2, 2017)

Funding

Total funding raised
Total funding raised
$ 106m
Total funding raised
$ 875m
Total funding raised
$ 145m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Depomed
HQ
Newark, US
Employees
490

Depomed is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other.

View company
Aimmune Therapeutics
HQ
Brisbane, US
Employees
122↑ 20% increase

Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies.

View company
Flex Pharma
HQ
Boston, US
Employees
30

Flex Pharma, Inc. develops clinically proven products and treatments for muscle cramps and spasms.

View company
Genprex
HQ
Austin, US
Employees
8

Genprex is a biopharmaceutical company developing molecular therapies for the treatment of cancer.

View company